OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production leverages Chinese hamster ovary (CHO) cells due to their robustness in expressing complex molecules. Improving these processes involves adjusting various variables, including cell line selection, media ingredients, and bioreactor settings. A key goal is to increase antibody titer while lowering production costs and m